Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PUBLICATION: Wireless Sensor Networks 2009-19

This article was originally published in Clinica

Executive Summary

Healthcare-related developments in the burgeoning radiofrequency identification (RFID) sector feature in the Wireless Sensor Networks 2009-2019 report published this week by RFID specialists IDTechEx. The report examines the activities of 20 developers and marketers of the new WSN technology (ubiquitous sensor networks), and over 30 potential and actual applications; provides 10-year forecasts; and features explanations of the technology and a comprehensive glossary of the jargon. Cambridge, Massachusetts-based IDTechEx promises constant updates of the information, to capture the "rapid technical and commercial progress" of the sector. The 240-page report is priced at £1,250, €2,000, $2,500 and ¥325,000 (electronic copy, plus around 10% for additional hardcopy); for more information, go to: http://www.IDTechEx.com/wsn

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel